Sitagliptin also suppressed fasting hyperinsulinemia (Figure 2(f), p < 0.01) as well as enhancing insulin signaling in the liver of ob/ob mice, associated with increased insulin-induced AKT phosphorylation (Figure 2(g), p < 0.01). The gene discussed is AKT1; the disease is hyperinsulinism.